Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

HKG:6922 Statistics

Total Valuation

HKG:6922 has a market cap or net worth of HKD 1.20 billion. The enterprise value is 1.19 billion.

Market Cap	1.20B
Enterprise Value	1.19B

Important Dates

The next estimated earnings date is Friday, August 7, 2026.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:6922 has 244.71 million shares outstanding.

Current Share Class	149.03M
Shares Outstanding	244.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.05%
Owned by Institutions (%)	0.99%
Float	41.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.31
PB Ratio	22.20
P/TBV Ratio	21.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.95
EV / Sales	11.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-161.88

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.54.

Current Ratio	1.51
Quick Ratio	0.59
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-3.98
Interest Coverage	-22.25

Financial Efficiency

Return on equity (ROE) is -69.75% and return on invested capital (ROIC) is -27.56%.

Return on Equity (ROE)	-69.75%
Return on Assets (ROA)	-18.94%
Return on Invested Capital (ROIC)	-27.56%
Return on Capital Employed (ROCE)	-56.24%
Weighted Average Cost of Capital (WACC)	-0.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	180
Asset Turnover	0.66
Inventory Turnover	1.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.20% in the last 52 weeks. The beta is -0.85, so HKG:6922's price volatility has been lower than the market average.

Beta (5Y)	-0.85
52-Week Price Change	-0.20%
50-Day Moving Average	5.49
200-Day Moving Average	5.97
Relative Strength Index (RSI)	23.57
Average Volume (20 Days)	52,090

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6922 had revenue of HKD 106.02 million and -42.47 million in losses. Loss per share was -0.18.

Revenue	106.02M
Gross Profit	71.20M
Operating Income	-48.33M
Pretax Income	-49.47M
Net Income	-42.47M
EBITDA	-41.60M
EBIT	-48.33M
Loss Per Share	-0.18

Balance Sheet

The company has 39.73 million in cash and 29.16 million in debt, with a net cash position of 10.58 million or 0.04 per share.

Cash & Cash Equivalents	39.73M
Total Debt	29.16M
Net Cash	10.58M
Net Cash Per Share	0.04
Equity (Book Value)	54.01M
Book Value Per Share	0.23
Working Capital	34.48M

Cash Flow

In the last 12 months, operating cash flow was -6.48 million and capital expenditures -856,864, giving a free cash flow of -7.33 million.

Operating Cash Flow	-6.48M
Capital Expenditures	-856,864
Depreciation & Amortization	7.01M
Net Borrowing	-2.73M
Free Cash Flow	-7.33M
FCF Per Share	-0.03

Margins

Gross margin is 67.16%, with operating and profit margins of -45.59% and -40.06%.

Gross Margin	67.16%
Operating Margin	-45.59%
Pretax Margin	-46.66%
Profit Margin	-40.06%
EBITDA Margin	-39.24%
EBIT Margin	-45.59%
FCF Margin	n/a

Dividends & Yields

HKG:6922 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.54%
FCF Yield	-0.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6922 has an Altman Z-Score of 0.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.59
Piotroski F-Score	2